UCLA AI model could improve outcomes of prostate cancer focal therapy

AI tool detects possible metastatic breast cancer

Researchers at UT Southwestern Medical Center have developed a novel artificial intelligence model to improve the detection of breast cancer metastasis, which could reduce the need for needle or surgical biopsies.

May 24, 2024

Vol.50 No.21

Guest Editorial

Regulators must step in to safeguard patient data in the AI era

The healthcare sector’s necessary transition towards electronic health records (EHRs) has transformed patient care and operational efficiency.

May 17, 2024

Vol.50 No.20

By Mika Newton

Clinical Roundup

UCLA study: Combination of breast cancer and chemo may speed physical decline in older adults

Women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function, a UCLA-led study suggests.

May 17, 2024

Vol.50 No.20

Drugs & Targets

Leal Health announces next-gen AI patient support platform to enable cancer treatment navigation

Leal Health announced a first-of-its-kind GenAI single point of access technology designed to allow healthcare providers, caregivers, and cancer patients to understand diagnostics and identify personalized treatment options to support the treatment decision process.

May 17, 2024

Vol.50 No.20

Clinical Trials & Tribulations

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

Tumor heterogeneity is a well-recognized hurdle to successful cancer therapy, often leading to resistance and treatment failure.

May 10, 2024

Vol.50 No.19

By Sanju Sinha and Eytan Ruppin

Clinical Roundup

AI-based biomarker stratifies metastasis risk in patients with BCR post-prostatectomy

ArteraAI has validated its first multimodal artificial intelligence digital pathology-based post-radical prostatectomy biomarker for stratifying risk of metastasis and identifying differential absolute benefit for the addition of hormone therapy to salvage radiation therapy in radical prostatectomy patients with biochemical recurrence.

May 10, 2024

Vol.50 No.19

UCLA AI model could improve outcomes of prostate cancer focal therapy

YOU MAY BE INTERESTED IN

AI tool detects possible metastatic breast cancer

Regulators must step in to safeguard patient data in the AI era

UCLA study: Combination of breast cancer and chemo may speed physical decline in older adults

Leal Health announces next-gen AI patient support platform to enable cancer treatment navigation

Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity

AI-based biomarker stratifies metastasis risk in patients with BCR post-prostatectomy

Renew today!

Subscriber content

Login